- [Resource Hub](/) - [Blog](/?resource-type=blog-post#library) - Cold Case - Part 5: Case Closed # Cold Case - Part 5: Case Closed Cold Case: When Brain Tissue Holds the Evidence - Part 5 of 5 (Finale) (Prefer to listen to the full story? Click play to hear the finale of our series.) The Precision Point - Cold Case - Episode 5 (Finale) 0:00 / 0:00 Your browser does not support the audio element. Resolution --> The cases are closing. Not all at once, and not with the dramatic finality of a courtroom verdict. Science is quieter than that. But across laboratories worldwide, archived brain tissue that sat silent in paraffin for decades is finally delivering testimony. The evidence is speaking. And what it is saying is changing how we understand the diseases that steal memory, movement, and identity. ## The atlas builders The BRAIN Initiative Cell Census Network set out to catalog every cell type in the human brain. The Human Cell Atlas is building a reference map of every cell in the body, with the brain as one of its most complex chapters. Both projects require something that would have been unthinkable ten years ago: single-nucleus profiling from archived tissue, across dozens of brain regions, processed at multiple sites, with results consistent enough to merge into a single map. This is not a single-lab effort. It is a coordinated investigation involving institutions on different continents. And the fundamental requirement is the same one that governs any forensic analysis: the evidence handling must be standardized. If one lab's processing method yields a million intact nuclei from a section of prefrontal cortex and another lab's method yields four hundred thousand from the same region, those datasets cannot be compared. The batch effect would overwhelm the biology. The Singulator 200+ is what makes this standardization possible. Its two-cartridge workflow, GREEN for deparaffinization followed by YELLOW NIC+ for nuclei isolation, runs identically regardless of which institution processes the sample or which technician loads the cartridge. Replicate yields come back at 1.0 million nuclei and 1.0 million nuclei. Not 1.5 million one run and 0.4 million the next. For atlas-scale projects, that consistency is not a convenience. It is a prerequisite. ## Two kinds of evidence, one investigation The most comprehensive brain studies now use two complementary approaches on adjacent tissue sections from the same block. Think of it as two different forensic techniques applied to the same crime scene. Spatial transcriptomics maps gene activity while preserving the tissue's architecture. It tells you where cells are and what they are doing in the context of their neighbors. Picture a forensic photographer documenting every detail of a scene without disturbing it. Single-nucleus RNA sequencing, or snRNA-seq, dissociates the tissue into individual nuclei and reads each one's genetic activity at high resolution. It identifies cell types with a precision that spatial methods alone cannot match. This is the interrogation room: each witness, separated from the crowd, giving a detailed individual account. Neither approach alone tells the full story. Spatial data shows the geography but lacks the resolution to distinguish closely related cell types. snRNA-seq identifies every cell type but loses information about where those cells sat in the tissue. Together, they build the complete picture that brain atlas projects need. ### Platform-agnostic nuclei The Singulator 200+ produces nuclei compatible with the leading downstream platforms: 10x Genomics Flex for probe-based single-nucleus sequencing of degraded FFPE RNA, PERFF-seq for capturing rare cell populations, and Parse Biosciences and Fluent BioSciences for alternative sequencing chemistries. The snRNA-seq data from these nuclei also serves as companion data to inform 10x Xenium spatial transcriptomics on adjacent tissue sections. Researchers design their analytical strategy around their science, not their sample prep limitations. ## Cold cases being solved Alzheimer's disease has always looked different from patient to patient. Some lose memory first. Others lose language. Some decline slowly over fifteen years; others progress in three. Neuropathologists have known for decades that plaques and tangles, the hallmark pathology, vary enormously in distribution and density. The question that traditional microscopy could never answer is: what is happening at the cellular level to produce these different disease trajectories? Single-nucleus profiling of archived Alzheimer's tissue is starting to answer that question. By isolating nuclei from FFPE sections spanning different disease stages and brain regions, researchers can now identify which glial subtypes are activated, which neuronal populations are most vulnerable, and how the cellular landscape shifts as the disease progresses. The old case files, the tissue blocks archived after each patient's death, are yielding evidence that no amount of traditional histology could have extracted. Parkinson's research is seeing a similar transformation. The dopaminergic neurons of the substantia nigra, whose death causes the tremor and rigidity of the disease, represent a tiny fraction of the brain's total cell population. Manual processing methods, with their fifty to sixty percent tissue loss and bias toward robust immune cells, have routinely missed these fragile populations. Automated processing with the Singulator 200+ preserves them, and the circuitry they connect to, giving researchers their first clear view of the cellular neighborhood where Parkinson's begins. ## What becomes possible Consider what the world looks like when every biobank archive can be reopened. A thirty-year longitudinal aging study, where brain tissue was collected at autopsy from participants followed since their fifties, can now be profiled at single-nucleus resolution. The clinical records, the cognitive assessments, the brain imaging, the genetic data, all of it paired with cell-type-specific transcriptomics from the same patient's tissue. That kind of integrated dataset simply did not exist before because the tissue processing step could not deliver the quality or consistency required. Rare neurodegenerative diseases, the ones where only a few hundred brain donations exist worldwide, become accessible. When the Singulator 200+ can process inputs as small as a single 35-micrometer FFPE section and recover over a million intact nuclei, the allocation policies of biobanks stop being a bottleneck. Researchers no longer need to choose between preserving tissue for future studies and analyzing it now. A single section is enough. ### The complete workflow From a single FFPE section to sequencing-ready nuclei in about an hour of automated processing. The GREEN cartridge handles deparaffinization with a proprietary safe solvent, eliminating the need for a fume hood. The YELLOW NIC+ cartridge isolates and cleans up nuclei, removing myelin debris and cellular contaminants. Less than five minutes of hands-on time. Four pipetting steps. Operator-independent results. The evidence is handled with the care it deserves. ## From cold cases to closed cases Over the course of this series, we walked through the evidence lockers of neuroscience. We met the millions of FFPE blocks sitting in biobanks. We saw how formalin locks molecular data inside a chemical prison, and how myelin and fragile neurons make brain tissue uniquely difficult to work with. We confronted the uncomfortable truth that manual processing destroys fifty to sixty percent of the very evidence it is trying to collect, and that the survivors are a biased sample. Then the forensic lab arrived. Automated, standardized, gentle enough to preserve the fragile witnesses that manual methods break. Consistent enough to support multi-site atlas projects. Flexible enough to feed any downstream analytical platform. The Singulator 200+ did not create the science. The sequencing platforms, the spatial technologies, the computational methods that make sense of millions of transcriptomes, those came from the broader research community. What the Singulator 200+ did is solve the bottleneck that kept all of those downstream capabilities from reaching the richest source of clinical brain tissue on earth: the FFPE archive. The evidence is decades old. Researchers now have their best shot at cracking the case. And the cases are closing. Blog Series [Cold Case: When Brain Tissue Holds the Evidence](/resources/series/cold-case-when-brain-tissue-holds-the-evidence-series/) Part 5 of 5 [Previous Cold Case - Part 4: The Forensic Lab](/resources/cold-case-forensic-lab-singulator-200-plus/) [View all posts in this series](/resources/series/cold-case-when-brain-tissue-holds-the-evidence-series/) [Back to all resources](/#library) ## Similar resources [Field Guide](/resources/brain-tissue-complexity-myelin-lipids-neuronal-nuclei/) Singulator 200+ 2026 ### Overcoming Brain Tissue Complexity: Myelin, Lipids, and Fragile Neuronal Nuclei Brain FFPE tissue creates unique nuclei isolation challenges. Myelin debris, lipid contamination, and fragile neuronal nuclei require controlled automated processing to preserve cell-type diversity for single-nucleus sequencing. [Read Field Guide](/resources/brain-tissue-complexity-myelin-lipids-neuronal-nuclei/) [Field Guide](/resources/brain-tumor-ffpe-surgical-resection-single-cell/) Singulator 200+ 2026 ### Brain Tumor FFPE Processing: From Surgical Resection to Single-Nucleus Insights Process brain tumor FFPE from surgical resections on the Singulator 200+. Preserve cancer cells and immune populations for snRNA-seq and spatial analysis. [Read Field Guide](/resources/brain-tumor-ffpe-surgical-resection-single-cell/) [Ebook](/resources/cold-case-files-neuroscience-ffpe/) Singulator 200+ 2026 ### Cold Case Files:The Brain's Embedded Evidence How the Singulator 200+ preserves fragile neuronal nuclei from irreplaceable postmortem brain tissue. Automated FFPE processing for Alzheimer's, brain tumors, and brain atlases. [Read Ebook](/resources/cold-case-files-neuroscience-ffpe/) [Field Guide](/resources/ffpe-neurodegenerative-disease-research-singulator/) Singulator 200+ 2026 ### FFPE Nuclei Extraction for Neurodegenerative Disease Research Extract nuclei from FFPE brain tissue for Alzheimer's, Parkinson's, and Lewy body research. Longitudinal cohorts, cell-type preservation, and disease staging on the Singulator 200+. [Read Field Guide](/resources/ffpe-neurodegenerative-disease-research-singulator/) [Field Guide](/resources/integrating-snrna-seq-spatial-transcriptomics-brain-ffpe/) Singulator 200+ 2026 ### Integrating snRNA-seq with spatial transcriptomics for brain mapping Pair spatial transcriptomics with snRNA-seq from the same FFPE brain block. Block allocation, platform selection, and nuclei quality for multi-omic brain studies. [Read Field Guide](/resources/integrating-snrna-seq-spatial-transcriptomics-brain-ffpe/) [Field Guide](/resources/maximizing-limited-brain-tissue-sections-ffpe/) Singulator 200+ 2026 ### Maximizing Results from Limited Brain Tissue Sections Get high-quality nuclei from limited postmortem brain FFPE sections. Process NIH biobank allocations, hospital archives, and surgical specimens on the Singulator 200+. [Read Field Guide](/resources/maximizing-limited-brain-tissue-sections-ffpe/) [Field Guide](/resources/navigating-postmortem-brain-tissue-ffpe-genomics/) Singulator 200+ 2026 ### Navigating postmortem brain tissue for FFPE genomics Practical guide to postmortem brain FFPE challenges: necropsy timing, fixation variability, biobank sourcing, myelin debris, and how the Singulator 200+ standardizes nuclei extraction. [Read Field Guide](/resources/navigating-postmortem-brain-tissue-ffpe-genomics/) [Field Guide](/resources/reproducible-multi-site-brain-tissue-atlases-singulator/) Singulator 200+ 2026 ### Building Reproducible Multi-Site Brain Tissue Atlases Standardize brain FFPE nuclei extraction across consortium sites with the Singulator 200+. Eliminate operator variability, prevent batch effects, and scale for atlas projects. [Read Field Guide](/resources/reproducible-multi-site-brain-tissue-atlases-singulator/) [Blog](/resources/cold-case-contaminated-evidence-brain-tissue/) Singulator 200+ 2026 ### Cold Case - Part 2: Contaminated Evidence Manual extraction of nuclei from FFPE brain tissue destroys 50 to 60 percent of starting material. Fragile neurons die first, leaving biased results. Here is what goes wrong. [Read Blog](/resources/cold-case-contaminated-evidence-brain-tissue/) [Blog](/resources/cold-case-files-brain-tissue-evidence/) Singulator 200+ 2026 ### Cold Case - Part 1: The Cold Case Files Millions of FFPE brain tissue blocks sit in biobanks worldwide, holding decades of evidence about Alzheimer's, Parkinson's, and neurodegenerative diseases. What if we could reopen these cases? [Read Blog](/resources/cold-case-files-brain-tissue-evidence/) [Blog](/resources/cold-case-forensic-lab-singulator-200-plus/) Singulator 200+ 2026 ### Cold Case - Part 4: The Forensic Lab Manual FFPE processing destroys fragile neuronal nuclei and produces variable results. The Singulator 200+ automates the workflow with a two-cartridge system that delivers consistent, operator-independent results from irreplaceable brain tissue. [Read Blog](/resources/cold-case-forensic-lab-singulator-200-plus/) [Blog](/resources/cold-case-one-shot-at-the-scene/) Singulator 200+ 2026 ### Cold Case - Part 3: One Shot at the Scene NIH biobanks give you one allocation of irreplaceable brain tissue. Manual processing destroys 50-60% before analysis begins. The extraction method is the real variable. [Read Blog](/resources/cold-case-one-shot-at-the-scene/)